"Free parking for medical appointments is available. Covered pull-up access with wheelchair accessibility is located on the southeast corner of the building complex at entrance A. You may also park on the west side of the building in the general shopping parking lot and access medical offices via entrances C, D or E. Elevator and escalator access is available at all entrances. Shuttle Free shuttles are available to transport patients and visitors between One Hundred Oaks, Children's Hospital, and Medical Center East. Shuttles run regularly from 8:30 a.m. to 5 p.m. To catch a shuttle, simply go to the patient drop-off area outside of Medical Center East, Children’s Hospital main entry and One Hundred Oaks Mall G, A and E entrances."

During the past decade, Vanderbilt Health Pharmacy One Hundred Oaks conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vanderbilt Health Pharmacy One Hundred Oaks" #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator and "Medivation, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Vanderbilt Health Pharmacy One Hundred Oaks" are "Advanced, Androgen Receptor Positive Triple Negative Breast Cancer" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Vanderbilt Health Pharmacy One Hundred Oaks" in a lesser frequency.

Most popular intervention types in "Vanderbilt Health Pharmacy One Hundred Oaks" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Enzalutamide" (2 trials), "Placebo (for enzalutamide)" (1 trials) and "exemestane" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vanderbilt Health Pharmacy One Hundred Oaks" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Vanderbilt Health Pharmacy One Hundred Oaks". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Vanderbilt Health Pharmacy One Hundred Oaks, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Vanderbilt Health Pharmacy One Hundred Oaks, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".